- St.
- Cire takunkumin tafiye -tafiye a wannan lokacin ga Indiya da Afirka ta Kudu ya yi daidai da ɗaga takunkumin hana matafiya daga Burtaniya a ranar 1 ga Satumba, 2021.
- Ƙuntatawar tafiye -tafiye ta St. Kitts & Nevis tana nan don matafiya na duniya daga Brazil.
St. Cire takunkumin tafiye -tafiye a wannan lokacin ga Indiya da Afirka ta Kudu ya yi daidai da ɗaga takunkumin hana matafiya daga Burtaniya a ranar 18 ga Satumba, 2021, kuma ya yi daidai da ci gaba da hauhawar adadin allurar rigakafi a cikin Tarayya. Ƙuntatawar tafiye -tafiyen tana nan don matafiya na duniya daga Brazil.
Daga cikin yawan mutanen da St. Kitts & Nevis, 77.4% sun karɓi kashi ɗaya na allurar AstraZeneca/Oxford, tare da kashi 70.3% na yawan balagaggun mutane cikakke; tsakanin yara da matasa tsakanin shekarun 12 - 17, 10.9% na sun sami kashi na farko na allurar Pfizer/BioNTech tare da kashi 6.8% bayan sun sami allurai biyu. (Ƙididdiga kamar na Oktoba 19, 2021).
Tun daga ranar 7 ga Oktoba, 2021, an rage “Hutu a Wuri” zuwa awanni 24, tare da gwajin isa ga RT PCR da ake buƙata a kan otal -otal da masauki. Za a samar da sakamakon gwaji a cikin “Hutu a Wuri” na awanni 24. Waɗannan matafiya waɗanda ke da sakamakon gwaji mara kyau na iya haɗawa cikin Tarayyar bayan lokacin awa 24 ya wuce kuma ya more abubuwan da ba su da yawa St. Kitts & Nevis tayin da suka haɗa da, cin abinci a cikin gidajen abinci, fuskantar ɗabi'a a ɗayan sandunan rairayin bakin teku na gida akan "The Strip," yana ziyartar abubuwan jan hankali na musamman da na musamman, tafiya cikin ruwa mai tsabta, yin tafiya da aman wuta, siyan kasuwannin kasuwancin mu na gida ko kawai chilling a daya daga cikin rairayin bakin teku.
Kamar yadda aka sanar a ranar 29 ga Mayu, 2021 matafiya masu cikakken allurar rigakafi ne kawai za a ba da izinin shiga Tarayya.
- Ana keɓance keɓaɓɓu ga Jama'a da Mazauna Tarayyar St.
- Duk Yarjejeniyar Tafiya da Bukatun da suka rage don Tarayyar St. Kitts & Nevis, gami da ƙaddamar da sakamakon gwaji mara kyau daga gwajin RTR PCR sa'o'i 72 kafin isowa.
Ana ɗaukar matafiyi cikakken allurar rigakafi lokacin da makonni biyu suka wuce tun lokacin da suka karɓi kashi na biyu na jerin allurar rigakafi guda biyu (Pfizer/BioNTech, Moderna, AstraZeneca/Oxford, Sinopharm ko Sinovac), ko makonni biyu bayan sun karɓi allurar rigakafi guda ɗaya ( Johnson da Johnson). An yarda da haɗa alluran rigakafi na St. Kitts da Nevis.